SRPT Sarepta Therapeutics Options Ahead of EarningsAnalyzing the options chain and the chart patterns of SRPT Sarepta Therapeuticsprior to the earnings report this week,
I would consider purchasing the 120usd strike price Calls with
an expiration date of 2025-8-15,
for a premium of approximately $9.30.
If these options prove to be profitable prior t
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.4 USD
235.24 M USD
1.90 B USD
91.14 M
About Sarepta Therapeutics, Inc.
Sector
Industry
CEO
Douglas S. Ingram
Website
Headquarters
Cambridge
Founded
1980
FIGI
BBG00JVXHBD4
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Sarepta Therapeutics Potential Buyout SoonIf you haven`t bought SRPT here:
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than $10Mil that SRPT
SRPT strong supportSRPT is at a very strong support at the moment and entries can be made now if fundamentals of the company are strong
Entry @ CMP or 107 to 100
SL @ 97
TP 1 @ 120
TP 2 @ 132
This is when we are expecting that it will bounce back up from the strong support of 105
104-106 range (Strong Suppor
SRPT (Sarepta) is Bull to at least 72.81Prediction: SRPT (Sarepta) is Bull to at least 72.81
Reasons:
A good/decent Bull Pattern has emerged (Before closing) that is pointing upwards, and the Trends momentum is strong enough to push through the current resistance and reach the next resistance point of 72.81. And also, the main index for
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SRPT5657414
Sarepta Therapeutics, Inc. 1.25% 15-SEP-2027Yield to maturity
4.72%
Maturity date
Sep 15, 2027
See all 0L35 bonds
Curated watchlists where 0L35 is featured.
Related stocks
Frequently Asked Questions
The current price of 0L35 is 53.8 USD — it has decreased by −0.15% in the past 24 hours. Watch SAREPTA THERAPEUTICS INC COM USD0.0001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SAREPTA THERAPEUTICS INC COM USD0.0001 stocks are traded under the ticker 0L35.
0L35 stock has fallen by −3.38% compared to the previous week, the month change is a −32.79% fall, over the last year SAREPTA THERAPEUTICS INC COM USD0.0001 has showed a −54.21% decrease.
We've gathered analysts' opinions on SAREPTA THERAPEUTICS INC COM USD0.0001 future price: according to them, 0L35 price has a max estimate of 209.00 USD and a min estimate of 70.00 USD. Watch 0L35 chart and read a more detailed SAREPTA THERAPEUTICS INC COM USD0.0001 stock forecast: see what analysts think of SAREPTA THERAPEUTICS INC COM USD0.0001 and suggest that you do with its stocks.
0L35 reached its all-time high on Jun 21, 2024 with the price of 175.2 USD, and its all-time low was 48.2 USD and was reached on Apr 9, 2025. View more price dynamics on 0L35 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0L35 stock is 2.20% volatile and has beta coefficient of 1.22. Track SAREPTA THERAPEUTICS INC COM USD0.0001 stock price on the chart and check out the list of the most volatile stocks — is SAREPTA THERAPEUTICS INC COM USD0.0001 there?
Today SAREPTA THERAPEUTICS INC COM USD0.0001 has the market capitalization of 5.22 B, it has decreased by −2.21% over the last week.
Yes, you can track SAREPTA THERAPEUTICS INC COM USD0.0001 financials in yearly and quarterly reports right on TradingView.
SAREPTA THERAPEUTICS INC COM USD0.0001 is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
0L35 earnings for the last quarter are 1.50 USD per share, whereas the estimation was 1.88 USD resulting in a −20.32% surprise. The estimated earnings for the next quarter are −3.14 USD per share. See more details about SAREPTA THERAPEUTICS INC COM USD0.0001 earnings.
SAREPTA THERAPEUTICS INC COM USD0.0001 revenue for the last quarter amounts to 658.41 M USD, despite the estimated figure of 627.59 M USD. In the next quarter, revenue is expected to reach 687.47 M USD.
0L35 net income for the last quarter is 159.05 M USD, while the quarter before that showed 33.61 M USD of net income which accounts for 373.21% change. Track more SAREPTA THERAPEUTICS INC COM USD0.0001 financial stats to get the full picture.
No, 0L35 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 1.37 K employees. See our rating of the largest employees — is SAREPTA THERAPEUTICS INC COM USD0.0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAREPTA THERAPEUTICS INC COM USD0.0001 EBITDA is 271.97 M USD, and current EBITDA margin is 14.30%. See more stats in SAREPTA THERAPEUTICS INC COM USD0.0001 financial statements.
Like other stocks, 0L35 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAREPTA THERAPEUTICS INC COM USD0.0001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAREPTA THERAPEUTICS INC COM USD0.0001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAREPTA THERAPEUTICS INC COM USD0.0001 stock shows the strong sell signal. See more of SAREPTA THERAPEUTICS INC COM USD0.0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.